Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04750616
PHASE2

NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial

Sponsor: Kaiser Permanente

View on ClinicalTrials.gov

Summary

A Randomized, Double-blind, placebo-controlled Trial to Evaluate the Efficacy of Oral Nam for the Prevention of Acute Kidney Injury in Patients Undergoing On-Pump Cardiac Surgery

Official title: NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury (NACAM) Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

304

Start Date

2021-09-13

Completion Date

2025-06-30

Last Updated

2025-03-12

Healthy Volunteers

No

Interventions

DRUG

Niacinamide

Niacinamide 3 grams on the day of surgery and post-surgical days one and two

DRUG

Placebo

Matched placebo on the day of surgery and post-surgical days one and two

Locations (1)

Kaiser Permanente San Francisco Medical Center

San Francisco, California, United States